Global Insulinoma Market Growth (Status and Outlook) 2025-2031

September 2025 | 100 pages | ID: GDAA8771840AEN
LP Information

Abstracts

According to this study, the global Insulinoma market size will reach US$ million by 2031.

An insulinoma is a tumor of the pancreas that is derived from beta cells and secretes insulin. It is a rare form of a neuroendocrine tumor. Most insulinomas are benign in that they grow exclusively at their origin within the pancreas.

United States market for Insulinoma is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Insulinoma is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Insulinoma is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Insulinoma players cover Abcam, Ciron Group, Pfizer, Entax Medical, Olympus, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Insulinoma Industry Forecast” looks at past sales and reviews total world Insulinoma sales in 2024, providing a comprehensive analysis by region and market sector of projected Insulinoma sales for 2025 through 2031. With Insulinoma sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Insulinoma industry.

This Insight Report provides a comprehensive analysis of the global Insulinoma landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Insulinoma portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Insulinoma market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Insulinoma and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Insulinoma.

This report presents a comprehensive overview, market shares, and growth opportunities of Insulinoma market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Benign
• Metastatic

Segmentation by Application:

• Hospital
• Clinic
• Research and Academic Institutions
• Biotechnology and Pharmaceutical Companies

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Abcam
• Ciron Group
• Pfizer
• Entax Medical
• Olympus
• Boston Scientific Corporation
• Medtronic
• Cook Medical

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Insulinoma Market Size (2020-2031)
  2.1.2 Insulinoma Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Insulinoma by Country/Region (2020, 2024 & 2031)
2.2 Insulinoma Segment by Type
  2.2.1 Benign
  2.2.2 Metastatic
2.3 Insulinoma Market Size by Type
  2.3.1 Insulinoma Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Insulinoma Market Size Market Share by Type (2020-2025)
2.4 Insulinoma Segment by Application
  2.4.1 Hospital
  2.4.2 Clinic
  2.4.3 Research and Academic Institutions
  2.4.4 Biotechnology and Pharmaceutical Companies
2.5 Insulinoma Market Size by Application
  2.5.1 Insulinoma Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Insulinoma Market Size Market Share by Application (2020-2025)

3 INSULINOMA MARKET SIZE BY PLAYER

3.1 Insulinoma Market Size Market Share by Player
  3.1.1 Global Insulinoma Revenue by Player (2020-2025)
  3.1.2 Global Insulinoma Revenue Market Share by Player (2020-2025)
3.2 Global Insulinoma Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 INSULINOMA BY REGION

4.1 Insulinoma Market Size by Region (2020-2025)
4.2 Global Insulinoma Annual Revenue by Country/Region (2020-2025)
4.3 Americas Insulinoma Market Size Growth (2020-2025)
4.4 APAC Insulinoma Market Size Growth (2020-2025)
4.5 Europe Insulinoma Market Size Growth (2020-2025)
4.6 Middle East & Africa Insulinoma Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Insulinoma Market Size by Country (2020-2025)
5.2 Americas Insulinoma Market Size by Type (2020-2025)
5.3 Americas Insulinoma Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Insulinoma Market Size by Region (2020-2025)
6.2 APAC Insulinoma Market Size by Type (2020-2025)
6.3 APAC Insulinoma Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Insulinoma Market Size by Country (2020-2025)
7.2 Europe Insulinoma Market Size by Type (2020-2025)
7.3 Europe Insulinoma Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Insulinoma by Region (2020-2025)
8.2 Middle East & Africa Insulinoma Market Size by Type (2020-2025)
8.3 Middle East & Africa Insulinoma Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL INSULINOMA MARKET FORECAST

10.1 Global Insulinoma Forecast by Region (2026-2031)
  10.1.1 Global Insulinoma Forecast by Region (2026-2031)
  10.1.2 Americas Insulinoma Forecast
  10.1.3 APAC Insulinoma Forecast
  10.1.4 Europe Insulinoma Forecast
  10.1.5 Middle East & Africa Insulinoma Forecast
10.2 Americas Insulinoma Forecast by Country (2026-2031)
  10.2.1 United States Market Insulinoma Forecast
  10.2.2 Canada Market Insulinoma Forecast
  10.2.3 Mexico Market Insulinoma Forecast
  10.2.4 Brazil Market Insulinoma Forecast
10.3 APAC Insulinoma Forecast by Region (2026-2031)
  10.3.1 China Insulinoma Market Forecast
  10.3.2 Japan Market Insulinoma Forecast
  10.3.3 Korea Market Insulinoma Forecast
  10.3.4 Southeast Asia Market Insulinoma Forecast
  10.3.5 India Market Insulinoma Forecast
  10.3.6 Australia Market Insulinoma Forecast
10.4 Europe Insulinoma Forecast by Country (2026-2031)
  10.4.1 Germany Market Insulinoma Forecast
  10.4.2 France Market Insulinoma Forecast
  10.4.3 UK Market Insulinoma Forecast
  10.4.4 Italy Market Insulinoma Forecast
  10.4.5 Russia Market Insulinoma Forecast
10.5 Middle East & Africa Insulinoma Forecast by Region (2026-2031)
  10.5.1 Egypt Market Insulinoma Forecast
  10.5.2 South Africa Market Insulinoma Forecast
  10.5.3 Israel Market Insulinoma Forecast
  10.5.4 Turkey Market Insulinoma Forecast
10.6 Global Insulinoma Forecast by Type (2026-2031)
10.7 Global Insulinoma Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Insulinoma Forecast

11 KEY PLAYERS ANALYSIS

11.1 Abcam
  11.1.1 Abcam Company Information
  11.1.2 Abcam Insulinoma Product Offered
  11.1.3 Abcam Insulinoma Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Abcam Main Business Overview
  11.1.5 Abcam Latest Developments
11.2 Ciron Group
  11.2.1 Ciron Group Company Information
  11.2.2 Ciron Group Insulinoma Product Offered
  11.2.3 Ciron Group Insulinoma Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Ciron Group Main Business Overview
  11.2.5 Ciron Group Latest Developments
11.3 Pfizer
  11.3.1 Pfizer Company Information
  11.3.2 Pfizer Insulinoma Product Offered
  11.3.3 Pfizer Insulinoma Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Pfizer Main Business Overview
  11.3.5 Pfizer Latest Developments
11.4 Entax Medical
  11.4.1 Entax Medical Company Information
  11.4.2 Entax Medical Insulinoma Product Offered
  11.4.3 Entax Medical Insulinoma Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Entax Medical Main Business Overview
  11.4.5 Entax Medical Latest Developments
11.5 Olympus
  11.5.1 Olympus Company Information
  11.5.2 Olympus Insulinoma Product Offered
  11.5.3 Olympus Insulinoma Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Olympus Main Business Overview
  11.5.5 Olympus Latest Developments
11.6 Boston Scientific Corporation
  11.6.1 Boston Scientific Corporation Company Information
  11.6.2 Boston Scientific Corporation Insulinoma Product Offered
  11.6.3 Boston Scientific Corporation Insulinoma Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Boston Scientific Corporation Main Business Overview
  11.6.5 Boston Scientific Corporation Latest Developments
11.7 Medtronic
  11.7.1 Medtronic Company Information
  11.7.2 Medtronic Insulinoma Product Offered
  11.7.3 Medtronic Insulinoma Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 Medtronic Main Business Overview
  11.7.5 Medtronic Latest Developments
11.8 Cook Medical
  11.8.1 Cook Medical Company Information
  11.8.2 Cook Medical Insulinoma Product Offered
  11.8.3 Cook Medical Insulinoma Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 Cook Medical Main Business Overview
  11.8.5 Cook Medical Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Insulinoma Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Insulinoma Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Benign
Table 4. Major Players of Metastatic
Table 5. Insulinoma Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global Insulinoma Market Size by Type (2020-2025) & ($ millions)
Table 7. Global Insulinoma Market Size Market Share by Type (2020-2025)
Table 8. Insulinoma Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Insulinoma Market Size by Application (2020-2025) & ($ millions)
Table 10. Global Insulinoma Market Size Market Share by Application (2020-2025)
Table 11. Global Insulinoma Revenue by Player (2020-2025) & ($ millions)
Table 12. Global Insulinoma Revenue Market Share by Player (2020-2025)
Table 13. Insulinoma Key Players Head office and Products Offered
Table 14. Insulinoma Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Insulinoma Market Size by Region (2020-2025) & ($ millions)
Table 18. Global Insulinoma Market Size Market Share by Region (2020-2025)
Table 19. Global Insulinoma Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global Insulinoma Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas Insulinoma Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas Insulinoma Market Size Market Share by Country (2020-2025)
Table 23. Americas Insulinoma Market Size by Type (2020-2025) & ($ millions)
Table 24. Americas Insulinoma Market Size Market Share by Type (2020-2025)
Table 25. Americas Insulinoma Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas Insulinoma Market Size Market Share by Application (2020-2025)
Table 27. APAC Insulinoma Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC Insulinoma Market Size Market Share by Region (2020-2025)
Table 29. APAC Insulinoma Market Size by Type (2020-2025) & ($ millions)
Table 30. APAC Insulinoma Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe Insulinoma Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe Insulinoma Market Size Market Share by Country (2020-2025)
Table 33. Europe Insulinoma Market Size by Type (2020-2025) & ($ millions)
Table 34. Europe Insulinoma Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa Insulinoma Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa Insulinoma Market Size by Type (2020-2025) & ($ millions)
Table 37. Middle East & Africa Insulinoma Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Insulinoma
Table 39. Key Market Challenges & Risks of Insulinoma
Table 40. Key Industry Trends of Insulinoma
Table 41. Global Insulinoma Market Size Forecast by Region (2026-2031) & ($ millions)
Table 42. Global Insulinoma Market Size Market Share Forecast by Region (2026-2031)
Table 43. Global Insulinoma Market Size Forecast by Type (2026-2031) & ($ millions)
Table 44. Global Insulinoma Market Size Forecast by Application (2026-2031) & ($ millions)
Table 45. Abcam Details, Company Type, Insulinoma Area Served and Its Competitors
Table 46. Abcam Insulinoma Product Offered
Table 47. Abcam Insulinoma Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. Abcam Main Business
Table 49. Abcam Latest Developments
Table 50. Ciron Group Details, Company Type, Insulinoma Area Served and Its Competitors
Table 51. Ciron Group Insulinoma Product Offered
Table 52. Ciron Group Insulinoma Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. Ciron Group Main Business
Table 54. Ciron Group Latest Developments
Table 55. Pfizer Details, Company Type, Insulinoma Area Served and Its Competitors
Table 56. Pfizer Insulinoma Product Offered
Table 57. Pfizer Insulinoma Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Pfizer Main Business
Table 59. Pfizer Latest Developments
Table 60. Entax Medical Details, Company Type, Insulinoma Area Served and Its Competitors
Table 61. Entax Medical Insulinoma Product Offered
Table 62. Entax Medical Insulinoma Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. Entax Medical Main Business
Table 64. Entax Medical Latest Developments
Table 65. Olympus Details, Company Type, Insulinoma Area Served and Its Competitors
Table 66. Olympus Insulinoma Product Offered
Table 67. Olympus Insulinoma Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. Olympus Main Business
Table 69. Olympus Latest Developments
Table 70. Boston Scientific Corporation Details, Company Type, Insulinoma Area Served and Its Competitors
Table 71. Boston Scientific Corporation Insulinoma Product Offered
Table 72. Boston Scientific Corporation Insulinoma Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73. Boston Scientific Corporation Main Business
Table 74. Boston Scientific Corporation Latest Developments
Table 75. Medtronic Details, Company Type, Insulinoma Area Served and Its Competitors
Table 76. Medtronic Insulinoma Product Offered
Table 77. Medtronic Insulinoma Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 78. Medtronic Main Business
Table 79. Medtronic Latest Developments
Table 80. Cook Medical Details, Company Type, Insulinoma Area Served and Its Competitors
Table 81. Cook Medical Insulinoma Product Offered
Table 82. Cook Medical Insulinoma Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 83. Cook Medical Main Business
Table 84. Cook Medical Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Insulinoma Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Insulinoma Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Insulinoma Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Insulinoma Sales Market Share by Country/Region (2024)
Figure 8. Insulinoma Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Insulinoma Market Size Market Share by Type in 2024
Figure 10. Insulinoma in Hospital
Figure 11. Global Insulinoma Market: Hospital (2020-2025) & ($ millions)
Figure 12. Insulinoma in Clinic
Figure 13. Global Insulinoma Market: Clinic (2020-2025) & ($ millions)
Figure 14. Insulinoma in Research and Academic Institutions
Figure 15. Global Insulinoma Market: Research and Academic Institutions (2020-2025) & ($ millions)
Figure 16. Insulinoma in Biotechnology and Pharmaceutical Companies
Figure 17. Global Insulinoma Market: Biotechnology and Pharmaceutical Companies (2020-2025) & ($ millions)
Figure 18. Global Insulinoma Market Size Market Share by Application in 2024
Figure 19. Global Insulinoma Revenue Market Share by Player in 2024
Figure 20. Global Insulinoma Market Size Market Share by Region (2020-2025)
Figure 21. Americas Insulinoma Market Size 2020-2025 ($ millions)
Figure 22. APAC Insulinoma Market Size 2020-2025 ($ millions)
Figure 23. Europe Insulinoma Market Size 2020-2025 ($ millions)
Figure 24. Middle East & Africa Insulinoma Market Size 2020-2025 ($ millions)
Figure 25. Americas Insulinoma Value Market Share by Country in 2024
Figure 26. United States Insulinoma Market Size Growth 2020-2025 ($ millions)
Figure 27. Canada Insulinoma Market Size Growth 2020-2025 ($ millions)
Figure 28. Mexico Insulinoma Market Size Growth 2020-2025 ($ millions)
Figure 29. Brazil Insulinoma Market Size Growth 2020-2025 ($ millions)
Figure 30. APAC Insulinoma Market Size Market Share by Region in 2024
Figure 31. APAC Insulinoma Market Size Market Share by Type (2020-2025)
Figure 32. APAC Insulinoma Market Size Market Share by Application (2020-2025)
Figure 33. China Insulinoma Market Size Growth 2020-2025 ($ millions)
Figure 34. Japan Insulinoma Market Size Growth 2020-2025 ($ millions)
Figure 35. South Korea Insulinoma Market Size Growth 2020-2025 ($ millions)
Figure 36. Southeast Asia Insulinoma Market Size Growth 2020-2025 ($ millions)
Figure 37. India Insulinoma Market Size Growth 2020-2025 ($ millions)
Figure 38. Australia Insulinoma Market Size Growth 2020-2025 ($ millions)
Figure 39. Europe Insulinoma Market Size Market Share by Country in 2024
Figure 40. Europe Insulinoma Market Size Market Share by Type (2020-2025)
Figure 41. Europe Insulinoma Market Size Market Share by Application (2020-2025)
Figure 42. Germany Insulinoma Market Size Growth 2020-2025 ($ millions)
Figure 43. France Insulinoma Market Size Growth 2020-2025 ($ millions)
Figure 44. UK Insulinoma Market Size Growth 2020-2025 ($ millions)
Figure 45. Italy Insulinoma Market Size Growth 2020-2025 ($ millions)
Figure 46. Russia Insulinoma Market Size Growth 2020-2025 ($ millions)
Figure 47. Middle East & Africa Insulinoma Market Size Market Share by Region (2020-2025)
Figure 48. Middle East & Africa Insulinoma Market Size Market Share by Type (2020-2025)
Figure 49. Middle East & Africa Insulinoma Market Size Market Share by Application (2020-2025)
Figure 50. Egypt Insulinoma Market Size Growth 2020-2025 ($ millions)
Figure 51. South Africa Insulinoma Market Size Growth 2020-2025 ($ millions)
Figure 52. Israel Insulinoma Market Size Growth 2020-2025 ($ millions)
Figure 53. Turkey Insulinoma Market Size Growth 2020-2025 ($ millions)
Figure 54. GCC Countries Insulinoma Market Size Growth 2020-2025 ($ millions)
Figure 55. Americas Insulinoma Market Size 2026-2031 ($ millions)
Figure 56. APAC Insulinoma Market Size 2026-2031 ($ millions)
Figure 57. Europe Insulinoma Market Size 2026-2031 ($ millions)
Figure 58. Middle East & Africa Insulinoma Market Size 2026-2031 ($ millions)
Figure 59. United States Insulinoma Market Size 2026-2031 ($ millions)
Figure 60. Canada Insulinoma Market Size 2026-2031 ($ millions)
Figure 61. Mexico Insulinoma Market Size 2026-2031 ($ millions)
Figure 62. Brazil Insulinoma Market Size 2026-2031 ($ millions)
Figure 63. China Insulinoma Market Size 2026-2031 ($ millions)
Figure 64. Japan Insulinoma Market Size 2026-2031 ($ millions)
Figure 65. Korea Insulinoma Market Size 2026-2031 ($ millions)
Figure 66. Southeast Asia Insulinoma Market Size 2026-2031 ($ millions)
Figure 67. India Insulinoma Market Size 2026-2031 ($ millions)
Figure 68. Australia Insulinoma Market Size 2026-2031 ($ millions)
Figure 69. Germany Insulinoma Market Size 2026-2031 ($ millions)
Figure 70. France Insulinoma Market Size 2026-2031 ($ millions)
Figure 71. UK Insulinoma Market Size 2026-2031 ($ millions)
Figure 72. Italy Insulinoma Market Size 2026-2031 ($ millions)
Figure 73. Russia Insulinoma Market Size 2026-2031 ($ millions)
Figure 74. Egypt Insulinoma Market Size 2026-2031 ($ millions)
Figure 75. South Africa Insulinoma Market Size 2026-2031 ($ millions)
Figure 76. Israel Insulinoma Market Size 2026-2031 ($ millions)
Figure 77. Turkey Insulinoma Market Size 2026-2031 ($ millions)
Figure 78. Global Insulinoma Market Size Market Share Forecast by Type (2026-2031)
Figure 79. Global Insulinoma Market Size Market Share Forecast by Application (2026-2031)
Figure 80. GCC Countries Insulinoma Market Size 2026-2031 ($ millions)